The association between atorvastatin administration and plasma total homocysteine levels in renal transplant recipients

Ali Monfared, Seyyede Zeinab Azimi * , Ehsan Kazemnezhad

Cited by CrossRef: 5

1- Wu D, Wu Y, Deng J. Changes in Homocysteine Levels Affect Serum Lipid Response to Atorvastatin in Patients With Acute Coronary Syndrome: A Retrospective Observational Study. Clin Appl Thromb Hemost. 2020;26 [Crossref]

2- Fu Y, Wang X, Kong W. Hyperhomocysteinaemia and vascular injury: advances in mechanisms and drug targets. British J Pharmacology. 2018;175(8):1173 [Crossref]

3- Majumder A, Behera J, Jeremic N, Tyagi S. Hypermethylation: Causes and Consequences in Skeletal Muscle Myopathy. J Cell Biochem. 2017;118(8):2108 [Crossref]

4- Papitha P, Sujeetha P, Balajee K, Sangeetha T, Anand A. Pharmacological Effects of Atorvastatin and Cholesterol and Blood Pressure. Current Research in Cardiovascular Pharmacology. 2016;6(1):17 [Crossref]

5- Morris G, Berk M, Walder K, O’Neil A, Maes M, Puri B. The lipid paradox in neuroprogressive disorders: Causes and consequences. Neuroscience & Biobehavioral Reviews. 2021;128:35 [Crossref]